🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢📢We are hiring! 3 jobs just opened, please apply, share with friends and colleagues, and join us at the City of London Centre - world class hub for cancer biotherapeutics! Research Fellow/Data Integration Scientist closing 15 Oct 2023 Nicholas McGranahan ucl.ac.uk/work-at-ucl/se…

Our CSO, Sergio Quezada, will be in Boston to present at the Annual TIL Therapies Summit, taking place from October 2-4. His presentation, “Precision Cell Therapies Targeting Immunogenic Clonal Neoantigens in Lung Cancer," will take place at 8:30 ET on October 3. #TILSummit

Was so much fun to review this brilliant manuscript by Peter Westcott Jacks Lab with James L Reading and my mentor Charles Swanton. Cutting edge mouse model work highlighting the importance of tumor heterogeneity on immunogenicity in cancer! nature.com/articles/s4158…

POV: Telling your parents you just won the The Nobel Prize... The Drew Weissman Lab

Are you an enthusiastic computational biologist want to know more about early cancer development? Come and join us in a CRUK project studying pre/cancer heterogeneity and evolution with organoids and other multi-omics tools! Early Cancer Institute, University of Cambridge Cambridge University jobs.cam.ac.uk/job/43452/

Exciting computational post-doc position available in our lab. Hate cancer? Love research? Enjoy harnessing computational tools to explore the interplay between cancer cell plasticity and cancer genome evolution? This job is made for you. rb.gy/a6koe

Cell therapy with tumor-infiltrating lymphocytes (#TILs): a safe, feasible and effective treatment modality for selected patients with metastatic #melanoma 📚 The past, present, and future of TIL therapy reviewed in Clinical Cancer Research 👉 bit.ly/3QuVjxj👈 #TIL #celltherapy

Registration is open for the Eighth International Cancer Immunotherapy Conference: Translating Science into Survival! Presented by CRI and ENCI, #CICON24 will take place September 8-11, 2024, in National Harbor, MD. Register now: bit.ly/3SGhlzD #CancerResearch

🤔The emergence of liquid biopsies is a step forward for the future of cancer early detection, but what biomarkers should we be looking for? Evie Fitzsimons (UCL Cancer Institute) says that part of the answer could be in our immune system. ➡️Read more: bit.ly/48YDGgE

Congratulations ⁦Sarah Blagden⁩ ⁦@MariamJHanjani⁩ and thanks to our funders ⁦Michelle Mitchell⁩ ⁦Science and Innovation at Cancer Research UK⁩ - I hope this will be the future of lung cancer prevention news.sky.com/story/groundbr…

Another proud PI moment from June, the lab’s spatial biology guru Andrei Enica describes the cellular ecosystems regulating T cell surveillance in premalignant lesions during pulmonary carcinogenesis at the UCL Cancer Institute conference; all from a blank canvas inside 18 months 👏

Today our study of the association between replication timing alterations and mutation acquisition during cancer evolution has been published in Nature Communications nature.com/articles/s4146…

For all the T cell receptor sequencers out there, the latest version of our analysis pipeline Decombinator 5.0 is live, and now on PiPy for greater ease of installtion ! Thanks to Matt Cowley for a huge amount of work ! pypi.org/project/decomb…

The new digs seem nice… bsky.app/profile/jamesr…

Our work on contrastive learning of T cell receptor representations is now out in Cell Systems! Give SCEPTR embeddings a try for your TCR analysis applications: sceptr.readthedocs.io/en/stable/

Nature research paper: Clonal driver neoantigen loss under EGFR TKI and immune selection pressures go.nature.com/4hJsDxd